MaaT Pharma
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.
8
Funding Rounds
$59.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| He*** Af****** | - | - |
Funding
Funding series
Funding Series Analysis
The company MaaT Pharma has raised a total of $24m in funding over 8 rounds.
Key Insights:
- MaaT Pharma March 2016 Series A Funding Round: $11m
- MaaT Pharma March 2016 Series A Funding Round: $11m
- MaaT Pharma July 2015 Seed Funding Round: $1m
- MaaT Pharma January 2015 Seed Funding Round: $1m
- MaaT Pharma Series B round, February 2020: $21.5m
- MaaT Pharma Series A round, March 2016: $12m
- MaaT Pharma Seed round, January 2015: $1.2m
- MaaT Pharma Seed round, July 2015: $1.2m
MaaT Pharma March 2016 Series A Funding Round
$11m
MaaT Pharma March 2016 Series A Funding Round
$11m
MaaT Pharma July 2015 Seed Funding Round
$1m
MaaT Pharma January 2015 Seed Funding Round
$1m
MaaT Pharma Series B round, February 2020
$21.5m
MaaT Pharma Series A round, March 2016
$12m
MaaT Pharma Seed round, January 2015
$1.2m
MaaT Pharma Seed round, July 2015
$1.2m
Industries
MaaT Pharma is active in the following industries: